Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK)

Historical Holders from Q1 2014 to Q3 2025

Symbol
ANIK on Nasdaq
CUSIP
035255108
Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
14.4M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
12.2M
Holdings value
$115M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
112
Number of buys
67
Number of sells
-37
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Trigran Investments, Inc. 11.2% $15.2M 1.62M Trigran Investments, Inc. Sep 30, 2025
Caligan Partners LP 9.95% $14.4M 1.44M Caligan Partners LP Nov 19, 2025
BlackRock, Inc. 6.8% -34.5% $14.5M -$8.94M 963K -38.2% BlackRock, Inc. Mar 31, 2025
BlackRock Portfolio Management LLC 5.5% $7.45M 793K BlackRock Portfolio Management LLC Sep 30, 2025
DIMENSIONAL FUND ADVISORS LP 4.5% $9.88M 657K Dimensional Fund Advisors LP Dec 31, 2024

Institutional Holders of Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 12.2M $115M -$5.97M $9.40 112
2025 Q2 12.7M $134M -$1.53M $10.58 101
2025 Q1 12.7M $191M +$2.18M $15.03 107
2024 Q4 12.5M $206M -$14.1M $16.46 107
2024 Q3 13.1M $324M -$7.57M $24.70 121
2024 Q2 13.2M $335M -$3.27M $25.33 113
2024 Q1 13.4M $340M -$1.18M $25.40 119
2023 Q4 11.2K $254K -$539K $22.66 1
2023 Q3 13M $242M -$5.56M $18.63 115
2023 Q2 13.1M $340M +$436K $25.98 116
2023 Q1 13.1M $376M -$1.05M $28.72 118
2022 Q4 13.1M $388M -$23.8M $29.60 123
2022 Q3 13.3M $317M -$2.36M $23.80 112
2022 Q2 12.8M $285M -$1.57M $22.32 116
2022 Q1 12.9M $325M +$2.54M $25.11 111
2021 Q4 13.5M $483M +$10.3M $35.83 125
2021 Q3 13.1M $559M -$406K $42.56 126
2021 Q2 13.1M $569M -$4.32M $43.29 135
2021 Q1 13.3M $543M -$15.1M $40.79 144
2020 Q4 13.5M $611M +$252K $45.26 154
2020 Q3 13.5M $479M -$7.3M $35.39 151
2020 Q2 13.8M $519M +$35.1M $37.73 153
2020 Q1 12.9M $374M -$23M $28.91 155
2019 Q4 13.2M $684M -$12.1M $51.85 184
2019 Q3 13.6M $749M -$19.5M $54.89 188
2019 Q2 14M $570M +$37.4M $40.62 163
2019 Q1 13.2M $399M +$13.1M $30.24 148
2018 Q4 12.8M $429M -$13.5M $33.61 156
2018 Q3 13.1M $554M -$31.4M $42.18 152
2018 Q2 13.9M $446M +$47.6M $32.00 162
2018 Q1 12.1M $603M +$11.4M $49.72 163
2017 Q4 12.4M $669M -$3.46M $53.91 164
2017 Q3 12.4M $719M +$3.28M $58.00 163
2017 Q2 12.3M $606M +$28M $49.34 151
2017 Q1 11.8M $514M +$108M $43.44 150
2016 Q4 11M $538M -$2.61M $48.96 152
2016 Q3 10.9M $521M -$20.6M $47.85 158
2016 Q2 11.5M $615M -$30.8M $53.65 157
2016 Q1 11.9M $531M -$11.2M $44.72 158
2015 Q4 13.2M $475M -$3.26M $38.16 150
2015 Q3 12.5M $397M +$11.1M $31.83 134
2015 Q2 11.9M $395M -$15.2M $33.03 134
2015 Q1 12.1M $497M +$17.8M $41.17 156
2014 Q4 11.7M $476M +$37M $40.74 158
2014 Q3 11M $405M +$34.1M $36.66 151
2014 Q2 9.99M $463M -$6.56M $46.33 160
2014 Q1 10.1M $415M +$53.5M $41.10 151